Broxuridine Plus Surgery in Treating Patients With Stage I or Stage II Prostate Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of broxuridine in treating patients who are
undergoing surgery for stage I or stage II prostate cancer. Broxuridine may help doctors
determine the rate of growth of prostate tumors and help them plan effective treatment